The natural history of chronic hepatitis B patients who spontaneously cleared serum HBsAg was investigated. A total of 351 patients with chronic hepatitis B were observed in our hospital for at least 3 yr. Seven of these patients became HBsAg negative during the follow-up period. HBsAg disappeared w
Delayed HBsAg clearance in chronic hepatitis B viral infection
β Scribed by Karen L. Lindsay; Allan G. Redeker; Mary Ashcavai
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 473 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Seven patients are described in whom HBsAg persisted for 13 to 98 months after acute viral hepatitis B and then became nondetectable. All patients subsequently developed anti-HBs. During the period of HBs-antigenemia, liver biopsies in five patients showed persistent viral hepatitis. Retrospectively, impending negativity of HBsAg was predictable in five patients by a decrease in HBsAg titer, and in four patients by persistent normalization of serum alanine aminotransferase. Although delayed clearance of HBsAg in patients with chronic hepatitis B virus infection is uncommon, it appears to be predictable.
A t least 90% (1-3) of adult patients with symptomatic acute viral hepatitis B (AVH-B) resolves the infection
π SIMILAR VOLUMES
CAH based on established criteria (7) and evidence of liver disease for greater than 6 months, were included in this study. Age, sex, drug history, alcohol intake and predisposing factors to HBV infection were recorded.
The presence of hepatitis B virus DNA and anti-b was examined in a longitudinal study of 24 patients known to be &infected during the course from acute to chronic hepatitis B virus infection. Fifteen patients (63%) were hepatitis B virus DNA positive in the first serum sample. Eleven of 14 patients,
## Abstract In this study, we have analyzed the evolution of serum HBsAg levels in 16 patients with chronic hepatitis B who showed an HBsAg seroconversion following antiviral therapy. The data showed that the clearance of serum HBsAg is slower than that of serum HBV DNA, which may reflect a slow ki